25.93BMarket Cap
30.42P/E TTM
Royalty Pharma PLC's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Royalty Pharma PLC is 7.60, ranking 94 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is 30.42, which is 1224.54% below the recent high of 402.86 and 68.76% above the recent low of 9.50.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.